About atrial fibrillation
Atrial fibrillation is the most common cardiac arrhythmia and affects nearly 7 million people in the European Union and the United States., AF currently represents a major economic burden for society and leads to potential life-threatening complications. AF increases the risk of stroke up to five-fold4, worsens the prognosis of patients with CV risk factors,, and doubles the risk of mortality with significant burden on patients, health care providers and payers. Hospitalizations for AF have increased dramatically (two-to-three-fold) in recent years., AF hospitalizations now represent a third of all hospitalizations for arrhythmia and mortality in the US and Europe. Seventy percent of the annual cost of AF management in Europe is driven by hospital care and interventional procedures.
 Fuster V et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. European Heart Journal (2006) 27, 1979-2030.
 Wattigney WA, Mensah GA & Croft JB. Increasing trends in hospitalization for atrial fibrillation in the US 1985 through 1999 Implications for primary prevention. Circulation. 2003;108:711-716.
 Dorian P et al. J Am Coll Cardiol. 2000;36:1303-1309
 Lloyd-Jones et al. Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study. Circulation. 2004; 110:1042-1046.
 Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998 Sep 8; 98(10):946-52.
 Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial
fibrillation in adults: national implications for rhythm management and
|SOURCE RecordAF registry|
Copyright©2009 PR Newswire.
All rights reserved